Patients with thalassemia major should be screened for CD, especially cases with associated autoimmune diseases and growth failure even without typical symptoms of CD by measuring tTG IgA and for positive serologic patients performing an intestinal biopsy. Here, TGM2 is linked to autoimmune disease.